Hunan Jiaoke Tianyi Technology Co., Ltd.

Hunan Er-Kang Pharmaceutical Co., Ltd. (stock code: 300267) was established in October 2003 and listed on the Shenzhen Stock Exchange on September 27, 2011. The company is located in the scenic *Liuyang Economic and Technological Development Zone. Since its establishment, the company has been engaged in the research and development, production, and sales of pharmaceutical products, mainly including pharmaceutical excipients, active pharmaceutical ingredients, and novel antibiotics.
The company is one of the domestic professional pharmaceutical excipient manufacturers with the *most comprehensive varieties and *largest scale, and is one of the few domestic enterprises possessing registration approvals for both the API and finished drug of a novel penicillin-class antibiotic—sulbenicillin sodium.
Er-Kang Pharmaceutical is a formulator and promoter of domestic pharmaceutical excipient industry standards. Adhering to the business philosophy of "Professionalism achieves the future, quality forges brilliance," it achieves specialized production, serialized varieties, scientific application, and quality service. At the same time, with the mission of "Everything for the safety of medicines," the company regards the quality and safety of pharmaceutical excipients and other products as its lifeblood. Leveraging its advantages in the pharmaceutical excipient field, it strives to improve the quality level of pharmaceutical excipients, promote the construction of a pharmaceutical excipient standards system, actively develop pharmaceutical excipient products for various formulations, achieve variety scaling and quality standardization, and endeavor to build the company into the * of China's pharmaceutical excipient industry.

Honors received since the company's listing:
In August 2011, awarded "Top Ten Pharmaceutical Excipient Brands"
In January 2012, awarded Forbes: 2012 China's * Most Promising Growth Enterprise Board Listed Companies (7th place)
In July 2012, awarded 2011 Golden Bull * Best Growth Enterprise Company (2nd place)
In August 2013, awarded "China Growth Enterprise Board Listed Companies Top 20 by Value" (8th place), "China Growth Enterprise Board Listed Companies Top Ten Management Teams" (10th place); awarded the 2012 (6th) Pharmaceutical Industry "Top Ten National Brands" title
In February 2014, awarded two honorary titles: "2013 Changsha Top 30 Industrial Enterprises" and "2013 Enterprise with Profits and Taxes Exceeding 100 Million Yuan"